Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT03588611

Completed

Reduce Bolus Injection of Bivalirudin

Acute Coronary Syndrome
NCT03920878

Withdrawn

Cataract DME - Peri vs. Intraop

Diabetic Macular Edema | Cataract
NCT02337491

Completed

Pembrolizumab +/- Bevacizumab for Recurrent GBM

Glioblastoma
NCT01006538

Completed

Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT) (MERLOT)

Macular Degeneration
NCT04584580

Unknown

D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia

Coronavirus Disease (COVID)19
NCT03423823

Completed

Ziv-aflibercept Efficacy in Better Regulating AMD (ZEBRA)

Wet Macular Degeneration | Wet Age-related Macular Degeneration
NCT03882424

Completed

A Study to Compare Pharmacokinetic and Safety of TRS003 to China-approved Bevacizumab and US-licensed Avastin®

Healthy
NCT02669589

Completed

Investigating Different Anticoagulants for Renal Replacement Therapy (RICH)

Acute Kidney Injury
NCT03015922

Unknown

Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma (MUKeleven)

Multiple Myeloma
NCT04121975

Unknown

CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer

Cervical Cancer
NCT02970032

Completed

Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin

Venous Thromboembolism | Pulmonary Embolism | Deep-Venous Thrombosis
NCT02257632

Completed

Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration (TIDE AMD)

Wet Age-Related Macular Degeneration
NCT02363621

Completed

Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DME

Diabetic Macular Edema
NCT01640444

Completed

Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC) (VISNU-2)

Colorectal Cancer Metastatic
NCT03907098

Unknown

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

Breast Cancer
NCT03905317

Unknown

Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene

Lung Adenocarcinoma
NCT01594281

Completed

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE) (PRIDE)

Proliferative Diabetic Retinopathy (PDR)
NCT03148132

Completed

VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP

Eye Diseases | Premature Birth | Retinal Disease | Retinopathy of Prematurity Both Eyes
NCT02047214

Terminated

Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy

Glioblastoma Multiforme
NCT00958581

Completed

Tranexamic Acid (TXA) Versus Epsilon Aminocaproic Acid (EACA) Versus Placebo for Spine Surgery

Scoliosis
NCT02672995

Unknown

Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation Trial

Brain Neoplasm
NCT02271126

Completed

TEG Anticoagulation Monitoring During ECMO

Extracorporeal Membrane Oxygenation Complication
NCT01169558

Completed

A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum.

Colorectal Cancer
NCT00091624

Completed

A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)

Multiple Myeloma
NCT00968435

Completed

Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma

Head and Neck Cancer
NCT00003726

Terminated

Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer

Lung Cancer
NCT01813773

Completed

Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study (ACT)

Proliferative Diabetic Retinopathy
NCT01783886

Completed

Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement (VIVID EAST)

Macular Edema
NCT01873768

Completed

Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement

Osteoarthritis
NCT02492087

Unknown

Topical Tranexamic Acid in Caesarean Section (TXACS)

Postpartum Haemorrhage
NCT02604719

Unknown

Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH

Postpartum Hemorrhage
NCT00826800

Terminated

Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer

Colon Cancer
NCT01012973

Completed

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) (GALILEO)

Retinal Vein Occlusion
NCT00700180

Completed

A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.

Non-Small Cell Lung Cancer
NCT01352039

Terminated

A Non-inferiority Study Comparing Two Heparin Sodium Preparations in Hip Fracture Surgery (HEP-SC)

Hip Fracture Surgery
NCT00974324

Unknown

Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell Lymphoma (PTCL)

T Cell Lymphoma
NCT00327106

Completed

Tranexamic Acid in HIp Fracture Surgery (THIF Study) (THIF)

Hip Fracture
NCT00062803

Completed

SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism

Pulmonary Embolism
NCT00429962

Completed

Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

Age-Related Macular Degeneration | Choroidal Neovascularization
NCT00327093

Terminated

Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases

Neoplasm Metastasis | Colorectal Cancer
NCT00806403

Completed

Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction (SWEDES)

Acute Myocardial Infarction
NCT00001713

Completed

Treatment for Blood Clots in the Veins of the Legs

Embolism | Thrombophlebitis
NCT00426998

Completed

Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD

Macular Degeneration | Choroidal Neovascularization
NCT03924440

Completed

Ovulation Double Check (Proov) Verification and Usability Testing

Ovulation Disorder
NCT02715336

Unknown

Efficacy and Safety of Medication Used to Stimulate Ovulation

Pregnancy | Ovarian Stimulation | Miscarriages | IVF Cycle | Egg Retrieval | Ovarian Hyperstimulation
NCT03904368

Unknown

The Value of Myomectomy in Women With Intramural Myoma Before IVF.

IVF | Fibroid Uterus
NCT04625959

Active, not recruiting

Optimizing Mindfulness and Acceptance Based Behavioral Treatment for Bulimia Nervosa and Binge Eating Disorder

Binge-Eating Disorder | Bulimia Nervosa | Binge Eating | Bulimia; Atypical | Binge-Eating and Purging Type Anorexia Nervosa
NCT02470169

Unknown

Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Women With Endometriosis

Subfertility
NCT02348255

Withdrawn

NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse

Recurrent Adult Brain Neoplasm | Adult Brain Glioblastoma
NCT02659384

Completed

Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer

Ovarian Neoplasms

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations